The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action

Abroad (travel likely)RecruitingPHASE2

Conditions

Type 1 Diabetes · Obesity

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Indiana University School of Medicine, Indianapolis, Indiana, United States
Contact: Study coordinator (Heba Ismail) · heismail@iu.edu · 317-278-7856
Contact: Study coordinator (HI Team) · hiteam@iu.edu · 317-278-7042

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity

Type 1 Diabetes (T1D) · Overweight · Obesity

Abroad (travel likely)RecruitingPHASE1

Neuss, Germany

Vey Low-Energy Ketogenic Therapy in Adults With Type 1 Diabetes and Obesity on Intensive Insulin Therapy Using Advanded Hybrid Closed Loop System

Type 1 Diabetes (T1D) · Obesity (Disorder)

Abroad (travel likely)Recruiting

Bari, Italy

Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes

Diabetes

Abroad (travel likely)RecruitingPHASE2

Tanta, Egypt

The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation

Type 1 Diabetes · Chronic Inflammation · Insulin Sensitivity

Abroad (travel likely)RecruitingPHASE2

Gentofte Municipality, Denmark